Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Debt / NOTE 3.000% 6/0
-
Market price (% of par)
-
139.85%
-
Total 13F principal
-
$132,463,000
-
Principal change
-
-$1,493,000
-
Total reported market value
-
$185,027,000
-
Number of holders
-
18
-
Value change
-
+$2,518,116
-
Number of buys
-
7
-
Number of sells
-
14
Institutional Holders of ARRAY BIOPHARMA INC - NOTE 3.000% 6/0 as of Q4 2016
As of 31 Dec 2016,
ARRAY BIOPHARMA INC - NOTE 3.000% 6/0 was held by
18 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$132,463,000
in principal (par value) of the bond.
The largest 10 bondholders included
DEERFIELD MANAGEMENT CO, CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP, Linden Advisors LP, Redmile Group, LLC, CSS LLC/IL, LAZARD ASSET MANAGEMENT LLC, BAKER BROS. ADVISORS LP, and GABELLI FUNDS LLC.
This page lists
18
institutional bondholders reporting positions
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.